Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over Time
Ocular Oncology and Pathology · 2021 · 7 (2) · 133-141
DOI: 10.1159/000509918 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ocular Oncology and Pathology, online erschienen am 15.12.2020. Verfasst von Christine D M Roelofsen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
In order to improve medical care for uveal melanoma (UM) patients, we need to monitor disease and survival to guide our research efforts. We analyzed the data of UM patients who underwent an enucleation at the Leiden University Medical Center over the last five decades and investigated trends in patient and tumor characteristics and survival.
Methods
Data were collected from charts and pathology reports from all patients who underwent an enucleation for UM between 1973 and 2019 (n = 1,212), of which 1,066 were primary enucleations; data were analyzed according to five time periods: 1973–1979 (n = 209), 1980–1989 (n = 148), 1990–1999 (n = 174), 2000–2009 (n = 280), and 2010–2019 (n = 401).
Results
Over time, mean patient age at the time of enucleation for UM increased from 54.9 to 64.7 years (p < 0.001), more tumors showed histopathological involvement of the ciliary body (p < 0.001), and were classified in a high TNM/AJCC class (p < 0.001). Overall, the 5- and 10-year UM-related survival rates were 0.68 and 0.59, respectively. Over time, survival showed no change in patients with tumors in AJCC stages I or III, with recently a slightly worse survival in stage II UM (p = 0.02).
Conclusion
Between 1973 and 2019, we found similar rates of UM-related survival following enucleation, although we noticed a strong increase in more unfavorable patient and tumor characteristics over time, such as an older age and larger tumor size. The lack of improvement indicates that more research should take place to develop adjuvant treatments to prevent metastases and efficient treatments once metastases develop.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Emergency Medicine, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Pathology, Section Ophthalmic Pathology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Zitieren
APA
Roelofsen, C. D. M., Wierenga, A. P. A., van Duinen, S., Verdijk, R. M., Bleeker, J., Marinkovic, M., Luyten, G. P. M., & Jager, M. J. (2021). Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over Time. Ocular Oncology and Pathology, 7(2), 133-141. https://doi.org/10.1159/000509918
Vancouver
Roelofsen CDM, Wierenga APA, van Duinen S, Verdijk RM, Bleeker J, Marinkovic M, et al. Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over Time. Ocular Oncology and Pathology. 2021;7(2):133-141. doi:10.1159/000509918
BibTeX
@article{Roelofsen2021,
author = {Roelofsen, Christine D M and Wierenga, Annemijn P A and van Duinen, Sjoerd and Verdijk, Robert M and Bleeker, Jaco and Marinkovic, Marina and Luyten, Gregorius P M and Jager, Martine J},
title = {Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over Time},
journal = {Ocular Oncology and Pathology},
year = {2021},
volume = {7},
number = {2},
pages = {133--141},
doi = {10.1159/000509918}
}
EUVIMED